Cleerly

That’s a wrap on #ACC25! 🎉 What a year! CCTA + AI analysis is gaining momentum, and we're more excited than ever about the future of cardiac care. Some of our favorite moments: ✨ Educating the Chicago community on AI-powered cardiac care at the American College of Cardiology's Community Health Fair ✨ A packed meet-and-greet with Cleerly leadership ✨ Fueling attendees with heart-healthy snacks & meals (We know some of you came for the food and we respect that 😉) ✨ Presenting late-breaker results demonstrating AI-QCT's predictive power for women's cardiovascular risk Gudrun Feuchtner, Alexander van Rosendael, MD PhD, Ibrahim Danad ✨ Connecting with colleagues, friends & innovators A huge thank you to the American College of Cardiology for an unforgettable event and for bringing thought leaders together to push cardiology forward. Missed us at the conference? Let's connect: https://lnkd.in/gdfHByJw #YesCCT #CTFirst #AIQCT #DigitalHealth #HealthcareInnovation

Don't be fooled, heart disease isn't a lost cause. With the right insights, we can empower patients to take control of their heart health. 💪❤️ From early detection to personalized care, it’s time to rethink heart attack prevention. Cleerly's AI-powered CCTA image analysis provides healthcare professionals with the data and clarity needed to make confident, informed decisions for their patients. 🩺💡 👉 Learn more here: https://lnkd.in/gEGM7ApB #HeartDisease #AprilFools #HealthcareInnovation #YesCCT #HeartAttacks

Behind every high-quality CCTA scan is a commitment to catching heart disease early and saving lives. 💪❤️ Congratulations to Envision Imaging at Plano on earning the Cleerly Certified Award! Their focus on high-quality CCTA imaging supports healthcare professionals in evaluating heart health with confidence. We're proud to partner with a team committed to raising the standard of cardiac care and empowering patients with clearer insights. 👏 🫶 #YesCCT #CCTA #CardiacImaging #CTScan #CTFirst

🚨Big news in Women’s Heart Health! 🚨Late-breaking research presented at #ACC25 reveals that AI-QCT enhances the identification of women at high risk for major adverse cardiovascular events (MACE). Led by Dr. Gudrun Feuchtner, this study reveals that specific plaque features in women present a higher risk for MACE compared to men. The research not only highlights the urgent need for tailored preventive strategies but also supports the adoption of AI-QCT into clinical practice for unbiased risk estimation in both men and women. Read the full press release to discover how this groundbreaking study could transform cardiac care for women: https://lnkd.in/gqP9MUWX #YesCCT #AIQCT #WomensHealth #HealthcareInnovation

✅ Day 2 at #ACC25 in the books! Thank you to everyone who stopped by our Meet & Greet to connect with our leadership and learn how Cleerly is transforming cardiac care with AI-powered, non-invasive tools for diagnosing and managing coronary artery disease. Our CEO & Founder, Dr. James Min, MD, joined a 'Cross-Industry Panel Discussion on Community Education, Cardiovascular Disease Prevention, and Screening Programs. In a Lounge & Learn session, our VP of Medical Affairs, Michelle Gearhart, spoke on 'Increasing Female Physician Leadership in Clinical Trials. We're proud to be part of these vital discussions. 👏❤️ But we’re not done yet! There’s still plenty of heart talk ahead. 💙 Come visit us at booth 16033. We’d love to chat about how we can work together to create a world without heart attacks. 🗓️ Full schedule here: https://lnkd.in/gtdjSHwr #ACC25 #YesCCT #CTFirst #HealthcareInnovation

No lunch plans? No problem! 🥗❤️ Stop by booth 16033 for a meet & greet + lunch buffet with our leadership team at #ACC25! Meet the physicians, clinical innovators, and pioneers helping shape the future of cardiac care. Connect with Founder & CEO James Min, MD, CMO James P Earls MD, FSCCT, CSO Udo Hoffmann MD MPH, and CCO Jim Hartman over great food and even better conversation. See you there! 👋 #YesCCT #DigitalHealth #HealthcareInnovation

🚀 #ACC25 is here, and so is Cleerly! 🚀 We're live at Booth 16033, ready to connect, showcase our latest clinical insights and give you a hands-on look at how our AI-powered technology is shaping the future of cardiac care. Live demos, expert discussions, and game-changing research—don’t miss out! 👉 Check out our full schedule & book a meeting here: https://lnkd.in/gtdjSHwr #DigitalHealth #HealthcareInnovation #YesCCT #CTFirst

We track risk factors for coronary artery disease (CAD), but how are we tracking the disease itself? 🔍🫀 Meet Cleerly COMPARE a revolutionary feature that empowers physicians to track CAD over time to help personalize treatment and optimize patient care. With COMPARE, healthcare professionals can: 🔍 Assess plaque stabilization or progression with AI-powered insights 🎯 Help guide treatment using analyses of two or more CCTAs 📈 Evaluate CAD progression over time for truly individualized care This isn't just about detection, it's about taking action. Learn more here: https://lnkd.in/g9QTMQSZ #HealthcareInnovation #CoronaryArteryDisease #DigitalHealth #YesCCT #CardiacCare

🚨 #ACC25 is almost here! 🚨 Team Cleerly is excited to join the American College of Cardiology to share the latest in cardiac research and innovation. https://lnkd.in/gngCCCdC This year, we’re unveiling late-breaking clinical findings on the role of AI-QCT in identifying unique cardiovascular risks for women, a potential breakthrough in personalized care and enhancing health equity. Join us for: 🔷 6 research abstracts 🔷 Health Equity Panel with CEO & Founder James Min, MD 🔷 Lounge & Learn Session with VP of Medical Affairs Michelle Gearhart 🔷 Meet & Greet with Cleerly Leadership Stop by booth #16033 for a live demo of our AI-enabled CCTA solution, delivering comprehensive, accurate and trackable insights to personalize heart attack prevention. 👉 Read the full press release: https://lnkd.in/gX_YRmdW #ACC #ACC25 #YesCCT #CTFirst

What an unforgettable day in Chicago! Have you ever seen a CT scanner on wheels?! 🤯💙 In partnership with Corazon Imaging, Philips and local physicians, we provided 14 Cleerly analyses and on-site CCTA scans to raise awareness, improve education, and embrace equitable access to advanced heart care. A HUGE thank you to the American College of Cardiology for the opportunity to connect with the Chicago community and provide education on how Cleerly empowers healthcare professionals with our noninvasive, AI-powered analysis. At Cleerly, we believe in a future where cardiac care is proactive, precise, and truly personalized. Everyone deserves the opportunity to take control of their heart health, and we are honored to play a role in making that a reality. ❤️✨ #ACC25 #YesCCT #CTFirst #HealthcareInnovation